我們已在上線！進一步了解

Inspire Medical Systems

INSP

市值 US$19.9億

68.79 USD

-1.33

1.9%

收盤時已更新 10月16日下午4:00 EDT

1天

-1.9%

5天

-1.71%

1個月

-5.44%

3個月

33.47%

6個月

21.86%

今年迄今

-25.45%

1年

-11.06%

5年

-72.24%

10年

175.38%

關於： Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and All other countries wherein, it generates a majority of its revenue from the United States. Its segment revenues are derived from the sales of its product, the Inspire system, to hospitals and ambulatory surgery centers in the U.S. and in selected countries in Europe and the Asia Pacific region.

員工： 1,333

醫療保健醫療器材

新聞

正面

中性

負面

市場情緒 3個月

正面 50%

中性 42.3%

負面 7.7%

Inspire Medical Systems, Inc. to Report Third Quarter 2026 Financial Results on November 2, 2026

MINNEAPOLIS, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release financial results for the third quarter 2026 after the close of trading on Monday, November 2. Inspire's management team will host a corresponding conference call beginning at 5:00 p.m. Eastern Time to discuss the financial results and recent business developments.

Inspire Medical Systems, Inc. to Report Third Quarter 2026 Financial Results on November 2, 2026

Zacks Investment Research

Inspire Medical Gains New CPT Codes for Hypoglossal Nerve Stimulation

INSP gains new Category I CPT codes for Inspire V procedures, creating a dedicated coding framework effective Jan. 1, 2028.

Inspire Medical Gains New CPT Codes for Hypoglossal Nerve Stimulation

Inspire Medical Systems, Inc. Announces Approval of New Hypoglossal Nerve Stimulation CPT® Codes by the AMA Editorial Panel

MINNEAPOLIS, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea (OSA), today announced that the American Medical Association (AMA) CPT® Editorial Panel has approved the establishment of a new set of Current Procedural Terminology (CPT®) codes that accurately describe and include the Inspire V system. The new Category I codes are scheduled to take effect on January 1, 2028.

Inspire Medical Systems, Inc. Announces Approval of New Hypoglossal Nerve Stimulation CPT® Codes by the AMA Editorial Panel

Zacks Investment Research

Here's Why You Should Retain INSP Stock in Your Portfolio for Now

Inspire Medical is navigating a major product transition as clinical evidence, patient access efforts and reimbursement progress support growth prospects.

Here's Why You Should Retain INSP Stock in Your Portfolio for Now

Zacks Investment Research

Zacks Industry Outlook Medical Systems, American Well and Butterfly Network

Medical Systems, American Well and Butterfly Network have been highlighted in this Industry Outlook article.

Zacks Industry Outlook Medical Systems, American Well and Butterfly Network

Zacks Investment Research

3 Medical Info Systems Stocks to Gain From GenAI Boom Amid Cyber Risk

INSP, AMWL and BFLY are positioned to gain from digital health and AI demand despite cybersecurity risks.

3 Medical Info Systems Stocks to Gain From GenAI Boom Amid Cyber Risk

Zacks Investment Research

Why Is Inspire (INSP) Down 4.1% Since Last Earnings Report?

Inspire (INSP) reported earnings 30 days ago. What's next for the stock?

Why Is Inspire (INSP) Down 4.1% Since Last Earnings Report?

Inspire Medical Systems, Inc. to Present at the Wells Fargo 21st Annual Healthcare Conference

MINNEAPOLIS, Aug. 26, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the Wells Fargo 21st Annual Healthcare Conference on Wednesday, September 9, 2026.

Inspire Medical Systems, Inc. to Present at the Wells Fargo 21st Annual Healthcare Conference

Zacks Investment Research

INSP Stock Rallies Nearly 40% YTD: Can Its Growth Story Continue?

Inspire Medical stock's 39.7% three-month surge is driven by the easing of reimbursement pressures, increasing Inspire V adoption and Project Horizon targeting longer-term expansion.

INSP Stock Rallies Nearly 40% YTD: Can Its Growth Story Continue?

Zacks Investment Research

Here's Why You Should Add INSP Stock to Your Portfolio Now

Inspire Medical's Inspire V adoption, clinical evidence and underpenetrated OSA market support growth despite coding and reimbursement headwinds.

Here's Why You Should Add INSP Stock to Your Portfolio Now

查看新聞排名

價格圖表採用Lightweight Charts™實作